MUTYH Gene Familial Adenomatous Polyposis Type 2 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Cancer Risk
The MUTYH Gene Familial Adenomatous Polyposis Type 2 NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This sophisticated genetic screening utilizes next-generation sequencing technology to analyze the MUTYH gene, which plays a critical role in DNA repair mechanisms. When mutations occur in this gene, individuals face significantly elevated risks for developing colorectal cancer and other associated malignancies.
What This Advanced Test Detects
Our comprehensive NGS-based analysis specifically targets:
- Pathogenic mutations in the MUTYH gene associated with MAP (MUTYH-associated polyposis)
- Both homozygous and compound heterozygous mutation patterns
- Specific variants linked to increased colorectal cancer susceptibility
- Genetic markers indicating hereditary cancer predisposition
- DNA repair pathway abnormalities affecting cellular integrity
Who Should Consider This Genetic Screening
This test is particularly recommended for individuals experiencing:
- Personal history of multiple colorectal polyps (typically 10-100 adenomas)
- Family history of colorectal cancer or polyposis syndromes
- Early-onset colorectal cancer diagnosis (before age 50)
- Unexplained gastrointestinal symptoms with family cancer patterns
- Relatives of individuals with confirmed MUTYH mutations
- Patients with attenuated familial adenomatous polyposis features
Significant Benefits of Early Detection
Undergoing MUTYH genetic testing provides numerous advantages:
- Enables personalized cancer surveillance and prevention strategies
- Facilitates early intervention for at-risk family members
- Provides clarity for reproductive planning and genetic counseling
- Reduces anxiety through definitive risk assessment
- Supports informed medical decision-making for preventive care
- May influence treatment approaches for diagnosed cancers
Understanding Your Test Results
Our comprehensive genetic report includes:
- Positive Result: Indicates presence of MUTYH mutations requiring enhanced surveillance and preventive measures
- Negative Result: Suggests standard cancer screening recommendations apply
- Variant of Uncertain Significance: Requires ongoing monitoring as research evolves
- Detailed interpretation by certified genetic specialists
- Personalized recommendations based on genetic findings
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
Nationwide Testing Accessibility
GGC DNA maintains comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.
Take Control of Your Genetic Health Today
Don’t leave your cancer risk to chance. Our MUTYH Gene Familial Adenomatous Polyposis Type 2 NGS Genetic DNA Test provides the clarity and confidence needed for proactive health management. Schedule your genetic counseling session and testing appointment today to begin your journey toward personalized cancer prevention.
Call or WhatsApp us now at +1(267) 388-9828 to book your comprehensive genetic assessment and take the first step toward understanding your hereditary cancer risk profile.
